Biotest Aktiengesellschaft Cash Flow Conversion Efficiency

Latest as of March 2025: -0.114x

Biotest Aktiengesellschaft cash flow conversion efficiency. Based on the latest financial reports, Biotest Aktiengesellschaft (BIO) has a cash flow conversion efficiency ratio of -0.114x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-58.10 Million ≈ $-67.93 Million USD) by net assets (€509.60 Million ≈ $595.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Biotest Aktiengesellschaft (2002–2024)

Cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. This chart illustrates how Biotest Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Biotest Aktiengesellschaft share price for real-time trading data and today's change.

Biotest Aktiengesellschaft Cash Flow Conversion Ratio Explained

Biotest Aktiengesellschaft cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Biotest Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotest Aktiengesellschaft ranked by their cash flow conversion efficiency. Also see Biotest Aktiengesellschaft market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Far Eastern Department Stores Ltd TW:2903	0.001x
Shanghai Chlor-Alkali Chemical Co Ltd A SHG:600618	0.012x
Guangdong Haomei New Material Co Lt SHE:002988	0.017x
Bajaj Mobility AG VI:BMAG	N/A
Whitestone REIT NYSE:WSR	0.008x
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
MoonLake Immunotherapeutics NASDAQ:MLTX	-0.261x
Shenzhen Infinova Ltd SHE:002528	-0.364x

Annual Cash Flow Conversion Efficiency for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. Review BIO free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€530.70 Million ≈ $620.44 Million	€60.90 Million ≈ $71.20 Million	0.115x	+2220.40%
2023-12-31	€498.90 Million ≈ $583.27 Million	€-2.70 Million ≈ $-3.16 Million	-0.005x	+95.04%
2022-12-31	€371.10 Million ≈ $433.85 Million	€-40.50 Million ≈ $-47.35 Million	-0.109x	-222.46%
2021-12-31	€380.40 Million ≈ $444.73 Million	€33.90 Million ≈ $39.63 Million	0.089x	+335.65%
2020-12-31	€441.60 Million ≈ $516.28 Million	€-16.70 Million ≈ $-19.52 Million	-0.038x	+46.32%
2019-12-31	€476.90 Million ≈ $557.55 Million	€-33.60 Million ≈ $-39.28 Million	-0.070x	+30.22%
2018-12-31	€495.20 Million ≈ $578.94 Million	€-50.00 Million ≈ $-58.46 Million	-0.101x	-202.38%
2017-12-31	€347.80 Million ≈ $406.61 Million	€34.30 Million ≈ $40.10 Million	0.099x	-46.02%
2016-12-31	€360.70 Million ≈ $421.70 Million	€65.90 Million ≈ $77.04 Million	0.183x	+97.71%
2015-12-31	€412.30 Million ≈ $482.02 Million	€38.10 Million ≈ $44.54 Million	0.092x	+489.25%
2014-12-31	€480.20 Million ≈ $561.40 Million	€-11.40 Million ≈ $-13.33 Million	-0.024x	-51.90%
2013-12-31	€460.70 Million ≈ $538.61 Million	€-7.20 Million ≈ $-8.42 Million	-0.016x	-116.63%
2012-12-31	€369.43 Million ≈ $431.91 Million	€34.73 Million ≈ $40.60 Million	0.094x	-54.92%
2011-12-31	€346.67 Million ≈ $405.29 Million	€72.28 Million ≈ $84.50 Million	0.208x	-17.59%
2010-12-31	€307.61 Million ≈ $359.63 Million	€77.83 Million ≈ $90.99 Million	0.253x	+115.51%
2009-12-31	€269.86 Million ≈ $315.50 Million	€31.68 Million ≈ $37.04 Million	0.117x	-13.75%
2008-12-31	€253.37 Million ≈ $296.22 Million	€34.49 Million ≈ $40.32 Million	0.136x	-5.47%
2007-12-31	€225.76 Million ≈ $263.94 Million	€32.51 Million ≈ $38.01 Million	0.144x	-1.85%
2006-12-31	€179.31 Million ≈ $209.64 Million	€26.31 Million ≈ $30.76 Million	0.147x	-12.46%
2005-12-31	€168.97 Million ≈ $197.55 Million	€28.32 Million ≈ $33.11 Million	0.168x	-28.46%
2004-12-31	€107.97 Million ≈ $126.22 Million	€25.29 Million ≈ $29.57 Million	0.234x	+46.49%
2003-12-31	€103.29 Million ≈ $120.75 Million	€16.52 Million ≈ $19.31 Million	0.160x	+619.93%
2002-12-31	€110.79 Million ≈ $129.53 Million	€2.46 Million ≈ $2.88 Million	0.022x	--

About Biotest Aktiengesellschaft

XETRA:BIO Germany

Market Cap

$976.15 Million

€834.96 Million EUR

Market Cap Rank

#8711 Global

#1144 in Germany

Share Price

€42.20

Change (1 day)

+0.00%

52-Week Range

€42.20 - €42.20

All Time High

€44.10